PMS31 THE IMPACT OF CHANGES IN ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB DOSES ON THE COSTS OF TREATING RHEUMATOID ARTHRITIS
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72184-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72184-2/fulltext
Title :
PMS31 THE IMPACT OF CHANGES IN ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB DOSES ON THE COSTS OF TREATING RHEUMATOID ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72184-2&doi=10.1016/S1098-3015(11)72184-2
First page :
A308
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
347